Pharmaceutical company Novo Nordisk is waiting on federal approval to sell its blockbuster GLP-1 weight-loss treatment as a ...

Weight-loss medications such as Ozempic, Wegovy, and Mounjaro have attracted widespread attention, making headlines across ...

Three years since COVID-19 abated, UnitedHealth Group, CVS Health and other insurers are still feeling the hangover, ...

The Justice Department announced that a federal jury in Louisiana convicted a nurse practitioner for her part in a Medicare ...

The early results for stop-loss claims, or claims for catastrophic losses, are in line with the insurer's expectations, ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

The Trump administration this April scrapped a Biden-era proposal that would have required state Medicaid programs and allowed federal Medicare to pay for some GLP-1s for obesity treatment. Instead, ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

The cuts have hit most of the eight minority health offices across HHS, in many cases laying off the majority of workers, if ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...